Drug release mechanisms of steroid eluting rings in cardiac pacemaker lead electrodes
暂无分享,去创建一个
Roland Zengerle | Simon Herrlich | Sven Spieth | Hans Gerstmann | Astrid Virnich | Franz Zipfel | Achim Kitschmann | Thorsten Göttsche | Peter Osypka | R. Zengerle | S. Herrlich | S. Spieth | P. Osypka | T. Göttsche | F. Zipfel | Hans Gerstmann | A. Virnich | Achim Kitschmann
[1] E J Topol,et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. , 1997, Journal of the American College of Cardiology.
[2] A. Oto,et al. Long-term clinical experience with a steroid-eluting active fixation ventricular electrode in children. , 1997, The American journal of cardiology.
[3] S. K. Chandrasekaran,et al. Use of osmotically active therapeutic agents in monolithic systems , 1980 .
[4] H. Mond,et al. A Comparative Study of the Action of Dexamethasone Sodium Phosphate and Dexamethasone Acetate in Steroid‐Eluting Pacemaker Leads , 2005, Pacing and clinical electrophysiology : PACE.
[5] H. Mond,et al. Rapid Decline in Acute Stimulation Thresholds with Steroid‐Eluting Active‐Fixation Pacing Leads , 2005, Pacing and clinical electrophysiology : PACE.
[6] M. Byrne,et al. Controlled drug release from contact lenses: A comprehensive review from 1965-present , 2011 .
[7] HARRY G. MONO,et al. The Electrode‐Tissue Interface: The Revolutionary Role of Steroid Elution , 1992, Pacing and clinical electrophysiology : PACE.
[8] H. Bonnemeier,et al. Long‐Term Superiority of Steroid Elution in Atrial Active Fixation Platinum Leads , 2000, Pacing and clinical electrophysiology : PACE.
[9] B. Gerritse,et al. A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. , 2008, The Annals of thoracic surgery.
[10] T. Higuchi. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.
[11] Diane J. Burgess,et al. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[12] A. Moritz,et al. Long-term follow-up after steroid-eluting epicardial pacemaker implantation in young children: a single centre experience. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] A. Chauhan,et al. Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[14] J. Triedman,et al. Comparison of Modern Steroid-Eluting Epicardial and Thin Transvenous Pacemaker Leads in Pediatric and Congenital Heart Disease Patients , 2005, Journal of Interventional Cardiac Electrophysiology.
[15] Delon Wu,et al. Long‐Term Performance of Transvenous, Steroid‐Eluting, High Impedance, Passive‐Fixation Ventricular Pacing Leads , 2004, Pacing and clinical electrophysiology : PACE.
[16] G. Kay,et al. Active Fixation Atrial Leads: Randomized Comparison of Two Lead Designs , 1989, Pacing and clinical electrophysiology : PACE.
[17] W. Spencer,et al. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. , 1995, Circulation.